Gert Matthijs
YOU?
Author Swipe
View article: Genetic modulators of diversity in biological expression of sickle cell anemia in patients from democratic republic of Congo
Genetic modulators of diversity in biological expression of sickle cell anemia in patients from democratic republic of Congo Open
Background: So far, the fetal hemoglobin (HbF) level is the most recognized modulator of sickle cell anemia (SCA) clinical expression. Variability in the HbF levels is associated with the SCA haplotypes and quantitative trait loci identifi…
View article: Absence of the dolichol synthesis gene DHRSX leads to N-glycosylation defects in Lec5 and Lec9 Chinese hamster ovary cells
Absence of the dolichol synthesis gene DHRSX leads to N-glycosylation defects in Lec5 and Lec9 Chinese hamster ovary cells Open
View article: The N-glycosylation defect in Lec5 and Lec9 CHO cells is caused by absence of the DHRSX gene
The N-glycosylation defect in Lec5 and Lec9 CHO cells is caused by absence of the DHRSX gene Open
Glycosylation-deficient Chinese hamster ovary (CHO) cell lines have been instrumental in the discovery of N-glycosylation machinery. Yet, the molecular causes of the glycosylation defects in the Lec5 and Lec9 mutants have been elusive, eve…
View article: A pseudoautosomal glycosylation disorder prompts the revision of dolichol biosynthesis
A pseudoautosomal glycosylation disorder prompts the revision of dolichol biosynthesis Open
View article: A pseudoautosomal glycosylation disorder prompts the revision of dolichol biosynthesis
A pseudoautosomal glycosylation disorder prompts the revision of dolichol biosynthesis Open
View article: N-glycosylation as a eukaryotic protective mechanism against protein aggregation
N-glycosylation as a eukaryotic protective mechanism against protein aggregation Open
The tendency for proteins to form aggregates is an inherent part of every proteome and arises from the self-assembly of short protein segments called aggregation-prone regions (APRs). While posttranslational modifications (PTMs) have been …
View article: Natural history of three late-diagnosed classic Galactosemia patients
Natural history of three late-diagnosed classic Galactosemia patients Open
The authors report the natural history of three patients with late-diagnosed Classic Galactosemia (CG) (at 16, 19 and 28 years). This was due to a combination of factors: absence of neonatal screening, absence of some typical acute neonata…
View article: Exploring attitudes and experiences with reproductive genetic carrier screening among couples seeking medically assisted reproduction: a longitudinal survey study
Exploring attitudes and experiences with reproductive genetic carrier screening among couples seeking medically assisted reproduction: a longitudinal survey study Open
View article: N-glycosylation as a eukaryotic protective mechanism against protein aggregation
N-glycosylation as a eukaryotic protective mechanism against protein aggregation Open
The tendency for proteins to form aggregates is an inherent part of every proteome and arises from the self-assembly of short protein segments called aggregation-prone regions (APRs). While post-translational modifications (PTMs) have been…
View article: Hydroxyurea treatment for adult sickle cell anemia patients in Kinshasa
Hydroxyurea treatment for adult sickle cell anemia patients in Kinshasa Open
Background : Despite a high incidence of sickle cell anemia, hydroxyurea (HU) treatment is rarely used in the DR Congo. This study aims to assess the efficacy of HU, the incidence of side effects that may limit its use in adults and to det…
View article: B1MG D3.2 Best practices for Next Generation Sequencing
B1MG D3.2 Best practices for Next Generation Sequencing Open
Determining variants in the genome involves several bioinformatic procedures, such as eliminating low-quality sequences, aligning sequencing reads to the human reference genome, and establishing confidence in the presence of a variant base…
View article: EVALUATE THE USE OF HYDREA IN TREATING CHILDREN WITH SICKLE CELL ANEMIA IN CENTRAL AFRICA'S RURAL AREA
EVALUATE THE USE OF HYDREA IN TREATING CHILDREN WITH SICKLE CELL ANEMIA IN CENTRAL AFRICA'S RURAL AREA Open
Sickle cell anemia is highly prevalent in Central Africa. The disease causes severe manifestations in children requiring treatment. Hydroxyurea is currently the most effective drug treatment. Therefore, we evaluated the use of HU in childr…
View article: Clinical and biological profile of Sickle Cell Anemia children in a rural area in Central Africa
Clinical and biological profile of Sickle Cell Anemia children in a rural area in Central Africa Open
Sickle Cell Anemia (SCA) is the most common genetic disease worldwide caused by a single mutation in the gene HBB. The disease severity is very variable and depends on many factors. We evaluated the clinical and biological profile o…
View article: Experiences of nonpregnant couples after receiving reproductive genetic carrier screening results in Belgium
Experiences of nonpregnant couples after receiving reproductive genetic carrier screening results in Belgium Open
View article: Clinical and laboratory characterization of adult sickle cell anemia patients in Kinshasa
Clinical and laboratory characterization of adult sickle cell anemia patients in Kinshasa Open
Background Sickle cell anemia (SCA) is a monogenic hemoglobinopathy associated with severe acute and chronic complications, with the highest incidence worldwide in Sub-Saharan Africa. The wide variability in clinical manifestations suggest…
View article: A PMM2-CDG caused by an A108V mutation associated with a heterozygous 70 kilobases deletion case report
A PMM2-CDG caused by an A108V mutation associated with a heterozygous 70 kilobases deletion case report Open
View article: Value of DNA testing in the diagnosis of sickle‐cell anemia in childhood in an environment with a high prevalence of other causes of anemia
Value of DNA testing in the diagnosis of sickle‐cell anemia in childhood in an environment with a high prevalence of other causes of anemia Open
Background Sickle‐cell anemia (SCA) is the most common genetic disease worldwide caused by a single mutation in the gene HBB . DNA testing can help to clarify the diagnosis when Hb electrophoresis is inconclusive. We evaluated the usefulne…
View article: Recommendations for whole genome sequencing in diagnostics for rare diseases
Recommendations for whole genome sequencing in diagnostics for rare diseases Open
View article: DNA testing for sickle cell anemia in Africa: Implementation choices for the Democratic Republic of Congo
DNA testing for sickle cell anemia in Africa: Implementation choices for the Democratic Republic of Congo Open
Background Hemoglobin‐based tests form the reference diagnostic test for SCA. In limited resource countries, these tests face limitations including cost, low sensitivity due to recurrent transfusions in endemic malaria region, and interfer…
View article: Reasons affecting the uptake of reproductive genetic carrier screening among nonpregnant reproductive‐aged women in Flanders (Belgium)
Reasons affecting the uptake of reproductive genetic carrier screening among nonpregnant reproductive‐aged women in Flanders (Belgium) Open
Reproductive genetic carrier screening (RGCS) allows to identify couples who have an increased likelihood of conceiving a child affected with an autosomal recessive or X‐linked monogenic condition. Multiple studies have reported on a wide …
View article: CDG or not CDG
CDG or not CDG Open
sponsorship: National Institute of Diabetes and Digestive and Kidney Diseases, Grant/Award Number: R01DK99551; National Institute of Neurological Disorders and Stroke, Grant/Award Number: U54 NS115198; The Rocket Fund (National Institute o…
View article: Knowledge, attitudes and preferences regarding reproductive genetic carrier screening among reproductive-aged men and women in Flanders (Belgium)
Knowledge, attitudes and preferences regarding reproductive genetic carrier screening among reproductive-aged men and women in Flanders (Belgium) Open
View article: CAMLG-CDG: a novel congenital disorder of glycosylation linked to defective membrane trafficking
CAMLG-CDG: a novel congenital disorder of glycosylation linked to defective membrane trafficking Open
The transmembrane domain recognition complex (TRC) pathway is required for the insertion of C-terminal tail-anchored (TA) proteins into the lipid bilayer of specific intracellular organelles such as the endoplasmic reticulum (ER) membrane.…
View article: Lack of NKG2D in MAGT1-deficient patients is caused by hypoglycosylation
Lack of NKG2D in MAGT1-deficient patients is caused by hypoglycosylation Open
View article: A Case of PMM2-CDG Caused by an A108V Mutation Associated With a Heterozygous 70 Kilobases Deletion
A Case of PMM2-CDG Caused by an A108V Mutation Associated With a Heterozygous 70 Kilobases Deletion Open
Background: Congenital Disorders of Glycosylation (CDG) are a large group of inherited inborn errors of metabolism with more than 140 different CDG types reported to date (1). The first characterized is also the most common, PMM2-CDG, with…
View article: <scp>COG6‐CDG</scp>: Novel variants and novel malformation
<span>COG6‐CDG</span>: Novel variants and novel malformation Open
Background Deficiency of Conserved Oligomeric Golgi (COG) subunits (COG1–8) is characterized by both N‐ and O‐protein glycosylation defects associated with destabilization and mislocalization of Golgi glycosylation machinery components (CO…
View article: Active site variants in STT3A cause a dominant type I congenital disorder of glycosylation with neuromusculoskeletal findings
Active site variants in STT3A cause a dominant type I congenital disorder of glycosylation with neuromusculoskeletal findings Open
View article: B1MG D3.1 - Quality metrics for sequencing
B1MG D3.1 - Quality metrics for sequencing Open
Next Generation Sequencing (NGS) is becoming increasingly used in clinical settings for the genomic analysis of germline and cancer samples. Hence, there is a need to establish guidelines that cover the minimum quality requirements for the…
View article: Aberrant sialylation in a patient with a HNF1α variant and liver adenomatosis
Aberrant sialylation in a patient with a HNF1α variant and liver adenomatosis Open
Glycosylation is a fundamental post-translational modification of proteins that boosts their structural diversity providing subtle and specialized biological properties and functions. All those genetic diseases due to a defective glycan bi…
View article: Clinical and radiological correlates of activities of daily living in cerebellar atrophy caused by PMM2 mutations (PMM2-CDG)
Clinical and radiological correlates of activities of daily living in cerebellar atrophy caused by PMM2 mutations (PMM2-CDG) Open